Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1180 | 1025 | 1244 | 1105 | 1751 | 2743 |
Fund Return | 18.05% | 2.5% | 24.43% | 3.39% | 11.86% | 10.62% |
Place in category | 944 | 1140 | 944 | 819 | 309 | 119 |
% in Category | 36 | 43 | 36 | 37 | 19 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Funbg | 15.79B | 17.23 | 2.61 | 9.75 | ||
Capital Group New Perspective Funzg | 15.79B | 18.04 | 3.39 | 10.62 | ||
Capital Group New Perspective Fuzgg | 15.79B | 18.06 | 3.40 | 10.63 | ||
Capital Group New Perspective Fubg | 15.79B | 17.23 | 2.61 | 9.75 | ||
Capital Group New Perspective Fubdg | 15.79B | 17.25 | 2.62 | 9.75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 13.68B | 10.76 | 3.46 | 13.87 | ||
Fundsmith Equity I Inc | 4.02B | 10.76 | 3.46 | 13.86 | ||
Fundsmith Equity R Acc | 575.41M | 10.16 | 2.85 | 13.17 | ||
Fundsmith Equity R Inc | 15.43M | 10.15 | 2.84 | 13.17 | ||
Fundsmith Equity T Acc | 3.87B | 10.66 | 3.36 | 13.75 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 3.78 | 585.25 | -1.73% | |
Microsoft | US5949181045 | 3.26 | 436.60 | -0.10% | |
Taiwan Semicon | TW0002330008 | 3.23 | 1,035.00 | -3.27% | |
Broadcom | US11135F1012 | 2.79 | 220.79 | +1.13% | |
Novo Nordisk B | DK0062498333 | 2.50 | 589.2 | -20.72% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review